Nasdaq:US$15.96 (+0.61) | HKEX:HK$25.50 (+1.40) | AIM:£2.38 (+0.13)
Other Ventures

Separate from our Oncology/Immunology R&D and commercial operations, our Other Ventures segment mainly provides Shanghai logistics and distribution services to third-party pharmaceutical companies.

This business is operated through a Good Supply Practice-certified joint venture that is 51% owned by HUTCHMED and 49% owned by Sinopharm, a leading distributor of pharmaceutical and healthcare products and a leading supply chain service provider in China.

Our Other Ventures also includes Shanghai Hutchison Pharmaceuticals, a non-consolidated joint venture that manufactures, markets and distributes a range of its own-brand prescription drug products across mainland China. This is a joint venture with Shanghai Pharmaceuticals. HUTCHMED retains a 5% interest in Shanghai Hutchison Pharmaceuticals.